This site is intended for UK Healthcare Professionals only

liver

liver-1280x720

Elafibranor approved as first medicine to treat adults with a rare liver disease

Elafibranor (Iqirvo) has been approved by the MHRA to treat adult patients with a rare type of liver disease known as primary biliary cholangitis

08 Oct 2024

liver

NAFLD in younger people increases risk of cancer...

Non-alcoholic fatty liver disease (NAFLD) increases the likelihood of developing cancer. Now a new study shows that the younger people develop NAFLD, the greater their cancer risk.

05 Oct 2023

Change privacy settings